Businessweek Archives

Genentech Herceptin


Special Report

GENENTECH HERCEPTIN

Genentech's Herceptin is the first drug to target a cancer-causing genetic defect. It blocks a gene found in 30% of breast-cancer victims. (800) 626-3553


Toyota's Hydrogen Man
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus